 | Up a level |
Number of items: 1.
Gerding, D. N., Hecht, D. W., Louie, T., Nord, C. E., Talbot, G. H., Cornely, O. A., Buitrago, M., Best, E., Sambol, S., Osmolski, J. R., Kracker, H., Locher, H. H., Charef, P. and Wilcox, M. (2016). Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C-difficile infection. J. Antimicrob. Chemother., 71 (1). S. 213 - 220. OXFORD: OXFORD UNIV PRESS. ISSN 1460-2091